Uniquity One (uni)
Clinical trials sponsored by Uniquity One (uni), explained in plain language.
-
New asthma drug shows promise in Mid-Stage trial
Disease control OngoingThis study tests a new medicine, solrikitug, for adults with asthma who still have symptoms despite using standard inhalers. About 145 people will receive either the drug or a placebo to see if it safely lowers certain blood cells linked to asthma inflammation. The goal is to bet…
Phase: PHASE2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated May 17, 2026 08:00 UTC
-
New drug aims to calm throat inflammation in adults
Disease control OngoingThis study tests an experimental drug called NSI-8226 (solrikitug) in 184 adults with eosinophilic esophagitis, a condition where white blood cells build up in the esophagus, causing trouble swallowing. Participants receive either the drug or a placebo to see if it reduces inflam…
Phase: PHASE2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC